Kirsten B. Goldberg - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Kirsten B. Goldberg

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

2021 David J. Pinato

ORCID

, Thomas U. Marron

ORCID

, Pallavi Shruti Mishra-Kalyani, Yutao Gong, Guo Wei

ORCID

, David Szafron, Elad Sharon, Anwaar Saeed

ORCID

, Tomi Jun

ORCID

, Sirish Dharmapuri, Abdul R. Naqash, Thoetchai Peeraphatdit, Anuhya Gampa, Yinghong Wang, Uqba Khan and 27 other authors

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Elaine Chang

ORCID

, Andrea B. Apolo

ORCID

ORCID

, Stephanie Chisolm

ORCID

, Vinay Duddalwar

ORCID

, Jason A. Efstathiou, Kirsten B. Goldberg

ORCID

, Donna E. Hansel

ORCID

, Ashish M. Kamat

ORCID

, Paul G. Kluetz, Seth P. Lerner, Elizabeth Plimack, Tatiana Prowell, Harpreet Singh, Daniel Suzman and 6 other authors

Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop

Upload

This paper is made freely available by the publisher.

2020 Preeti Narayan, Tatiana M. Prowell

ORCID

, Jennifer J. Gao

ORCID

, Laura L. Fernandes

ORCID

, Emily Li

ORCID

, Xiling Jiang, Junshan Qiu, Jianghong Fan, Pengfei Song, Jingyu Yu, Xinyuan Zhang, Bellinda L. King-Kallimanis, Wei Chen, Tiffany K. Ricks, Yutao Gong and 20 other authors

FDA Approval Summary: Alpelisib plus fulvestrant for patients with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer

Download from aacrjournals.org

This paper is made freely available by the publisher.

Sandra J. Casak, Martha Donoghue, Lola Fashoyin-Aje

ORCID

, Xiaoping Jiang, Lisa Rodriguez, Yuan-Li Shen, Yuan Xu

ORCID

, Xiling Jiang, Jiang Liu, Hong Zhao, William F. Pierce, Shubhangi Mehta, Kirsten B. Goldberg

ORCID

, Marc R. Theoret, Paul G. Kluetz and 2 other authors

FDA Approval Summary: Atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

Preeti Narayan, Sakar Wahby, Jennifer J. Gao

ORCID

, Laleh Amiri-Kordestani, Amna Ibrahim, Erik Bloomquist, Shenghui Tang, Yuan Xu, Jiang Liu, Wentao Fu, Pengfei Song, Bellinda L. King-Kallimanis, Sherry Hou, Yutao Gong, Shyam Kalavar and 9 other authors

FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1

Upload

This paper is made freely available by the publisher.

2019 Emily Y. Jen, Xin Gao, Liang Li

ORCID

, Luning Zhuang, Natalie E. Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong, Chao Liu, Christopher M. Sheth, Steven Bowen, Kirsten B. Goldberg

ORCID

, Ann T. Farrell and 2 other authors

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Download from aacrjournals.org

Missing publications? Search for publications with a matching author name.